findmyKOL
Clinical trialNCT06435858RecruitingPhase 2Interventional

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

SponsorCantonal Hospital GraubuendenEnrollment40Autosomal Dominant Polycystic Kidney Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Switzerland
  • University Hospital Zurich, Division of Nephrology

    Zurich, Canton of Zurich, Switzerland

    Recruiting
  • Cantonal Hospital Graubuenden

    Chur, Kanton Graubünden, Switzerland

    Lorena Roth, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Sept 2024
Primary completion
1 Jul 2025
Completion
31 Oct 2025
Last update posted
12 Sept 2025
Registered enrollment
40
Registry id
NCT06435858
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.